{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:28Z","timestamp":1793500528247,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10875-017-0425-3","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T18:38:55Z","timestamp":1501871935000},"page":"644-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Rituximab Restores IFN-\u03b3-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-\u03b3 Autoantibody"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8767","authenticated-orcid":false,"given":"Yusuke","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sakanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"key":"425_CR1","doi-asserted-by":"crossref","unstructured":"Gordin FM, Horsburgh CR Jr. Mycobacterium avium complex. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, 8th ed. Philadelphia: Saunders; 2015. pp. 2832-43.","DOI":"10.1016\/B978-1-4557-4801-3.00253-8"},{"key":"425_CR2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJM199105093241906","volume":"324","author":"CR Horsburgh","year":"1991","unstructured":"Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1332\u20138.","journal-title":"N Engl J Med"},{"key":"425_CR3","first-page":"77","volume":"53","author":"CC Lai","year":"2006","unstructured":"Lai CC, Lee LN, Ding LW, Yu CJ, Hsueh PR, Yang PC. Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Inf Secur. 2006;53:77\u201384.","journal-title":"J Inf Secur"},{"key":"425_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12879-016-1411-8","volume":"16","author":"S Sridhar","year":"2016","unstructured":"Sridhar S, Fung KS, Chan JF, Lam JY, Yip EK, Hung IF, et al. High recurrence rate supports need for secondary prophylaxis in non-HIV patients with disseminated Mycobacterium avium complex infection: a multi-center observational study. BMC Infect Dis. 2016;16:74.","journal-title":"BMC Infect Dis"},{"key":"425_CR5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367:725\u201334.","journal-title":"N Engl J Med"},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","volume":"115","author":"B Kampmann","year":"2005","unstructured":"Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115:2480\u20138.","journal-title":"J Clin Invest"},{"key":"425_CR7","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1086\/605581","volume":"49","author":"N Baerlecken","year":"2009","unstructured":"Baerlecken N, Jacobs R, Stoll M, Schmidt RE, Witte T. Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis. 2009;49:e76\u20138.","journal-title":"Clin Infect Dis"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","volume":"38","author":"R D\u00f6ffinger","year":"2004","unstructured":"D\u00f6ffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38:e10\u20134.","journal-title":"Clin Infect Dis"},{"key":"425_CR9","doi-asserted-by":"crossref","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi CY, Lin CH, Ho MW, Ding JY, Huang WC, Shih HP, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore). 2016;95:e3927.","journal-title":"Medicine (Baltimore)"},{"key":"425_CR10","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","volume":"119","author":"SK Browne","year":"2012","unstructured":"Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, et al. Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119:3933\u20139.","journal-title":"Blood"},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","volume":"58","author":"CA Czaja","year":"2014","unstructured":"Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, et al. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody. Clin Infect Dis. 2014;58:e115\u20138.","journal-title":"Clin Infect Dis"},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10875-010-9498-y","volume":"31","author":"T Hoshina","year":"2011","unstructured":"Hoshina T, Takada H, Sasaki-Mihara Y, Kusuhara K, Ohshima K, Okada S, et al. Clinical and host genetic characteristics of Mendelian. Susceptibility to mycobacterial diseases in Japan. J Clin Immunol. 2011;31:309\u201314.","journal-title":"J Clin Immunol"},{"key":"425_CR13","first-page":"146","volume":"9","author":"M Nakayama","year":"2017","unstructured":"Nakayama M, Oda H, Nakagawa K, Yasumi T, Kawai T, Izawa K, et al. Accurate clinical genetic testing for autoinflammatory diseases using the next-generation sequencing platform MiSeq. Biochem Biophys Rep. 2017;9:146\u201352.","journal-title":"Biochem Biophys Rep"},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","volume":"20","author":"K Shima","year":"2014","unstructured":"Shima K, Sakagami T, Tanabe Y, Aoki N, Moro H, Koya T, et al. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. J Infect Chemother. 2014;20:52\u20136.","journal-title":"J Infect Chemother"},{"key":"425_CR15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10156-013-0550-8","volume":"19","author":"H Shimizu","year":"2013","unstructured":"Shimizu H, Mizuno Y, Nakamura I, Fukushima S, Endo K, Matsumoto T. Vertebral osteomyelitis caused by non-tuberculous mycobacteria: case reports and review. J Infect Chemother. 2013;19:972\u20137.","journal-title":"J Infect Chemother"},{"key":"425_CR16","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf . Accessed 21 Dec 2016."},{"key":"425_CR17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuisa S, Abela L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26:454\u201370.","journal-title":"Semin Immunol"},{"key":"425_CR18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0961203313503912","volume":"22","author":"M Witt","year":"2013","unstructured":"Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, et al. German Registry of Autoimmune Diseases (GRAID) Investigators. Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE)\u2014results from a nationwide cohort in Germany (GRAID). Lupus. 2013;22:1142\u20139.","journal-title":"Lupus"},{"key":"425_CR19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ejh.12199","volume":"91","author":"W Barcellini","year":"2013","unstructured":"Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Di Bona E, Fattizzo B, et al. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia. Eur J Haematol. 2013;91:546\u201351.","journal-title":"Eur J Haematol"},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00415-014-7532-3","volume":"262","author":"R Iorio","year":"2015","unstructured":"Iorio R, Damato V, Alboini PE, Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol. 2015;262:1115\u20139.","journal-title":"J Neurol"},{"issue":"2","key":"425_CR21","doi-asserted-by":"crossref","first-page":"ofw093","DOI":"10.1093\/ofid\/ofw093","volume":"3","author":"N Pruetpongpun","year":"2016","unstructured":"Pruetpongpun N, Khawcharoenporn T, Damronglerd P, Suthiwartnarueput W, Apisarnthanarak A, Rujanavej S, et al. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-\u03b3 autoantibodies. Open Forum Infect Dis. 2016;3(2):ofw093.","journal-title":"Open Forum Infect Dis"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-017-0425-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T16:32:31Z","timestamp":1659285151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-017-0425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s10875-017-0425-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}